Hypertension and benign prostatic hyperplasia (BPH) are common disorders of aging men. As the world population is aging these two diseases are becoming a significant public health problem worldwide.
Approximately 30% of men treated for BPH have coexisting hypertension. The α-Adrenergic Blockers: Prazosin, Terazosin and Doxazosin are established agents in the therapy of hypertension, and are also effective drugs in the treatment of BPH. It is reasonable to use α-Adrenergic Blockers as the treatment of choice for men with hypertension and BPH.
The Journal of the Association of Physicians of India. 2014 Sep [Epub]
R P Mathur, Sumanlata Nayak, R Sivaramakrishnan, Vikas Jain